메뉴 건너뛰기




Volumn 4, Issue 7, 2009, Pages 1051-1053

Meropenem-clavulanate: A new strategy for the treatment of tuberculosis?

Author keywords

lactamases; BlaC; Combination therapy; Mycobacterium tuberculosis; Tuberculosis

Indexed keywords

4 AMINOAZOBENZENE; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; ETHAMBUTOL; GATIFLOXACIN; IMIPENEM; ISONIAZID; MEROPENEM; MOXIFLOXACIN; NITROCEFIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; SULTAMICILLIN;

EID: 67749118298     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200900155     Document Type: Short Survey
Times cited : (8)

References (10)
  • 1
    • 67749122007 scopus 로고    scopus 로고
    • WHO report
    • Geneva, Switzerland; last accessed, April 30, 2009
    • World Health Organization, WHO report 2007, Global Tuberculosis Control-Surveillance, Planning and Financing. (Geneva, Switzerland); http://www.who.int/tb/en/ (last accessed, April 30, 2009).
    • (2007) Global Tuberculosis Control-Surveillance, Planning and Financing
  • 2
    • 33847702524 scopus 로고    scopus 로고
    • C. Harper, Nat. Med. 2007, 13, 309-312.
    • (2007) Nat. Med. , vol.13 , pp. 309-312
    • Harper, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.